Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/8/2020
HK Researcher Discovers Anticancer NCE Phorbiplatin
1/7/2020
Innovent and Sirnaomics Cooperate to Combine Sintilimab and RNAi in th...
1/7/2020
Sorrento, Mabpharm File NDA for Infliximab Biosimilar
1/7/2020
NMPA Issues Interim Guidelines for Use of Real-World Data to Support D...
1/6/2020
GlycoMimetics and Apollomics Agree to Develop and Commercialize Uprole...
1/6/2020
Boehringer Ingelheim's Bet on Chinese CDMO Market Pays Off with Beigen...
1/6/2020
Eisai Launches First-in-Class Anti-epileptic Fycompa in China
1/3/2020
Recent Executive Moves
1/3/2020
CDMO WuXi STA Opens Manufacturing Facility to Produce Oligonucleotides
1/3/2020
NHC Issues the Clinical Pathways for Relevant Disease Groups (2019)
1/3/2020
Amgen Closes Acquisition of 20.5% Stake in BeiGene for $2.8B
1/2/2020
U.S.-China Phase I Trade Deal - An Opportunity Window MNCs Must Not Mi...
1/2/2020
NHC and SATCM Issues Rules for Internal Price Practices of Medical Ins...
1/2/2020
AstraZeneca Granted Chinese Approval for Its Hyperkalaemia Drug ZS-9
12/31/2019
Financial-related Company News in Brief
12/31/2019
NMPA Announces Initiation of Drug Business Application System
12/30/2019
Bankrupt Achaogen Sells China Assets to Xuanzhu for $4.5M
12/30/2019
China's 'Seaweed' Alzheimer's Drug Is Now Available to Patients
12/30/2019
NMPA Issues the Principles and Procedures for Drug Sampling
12/30/2019
Boehringer Ingelheim Approved to Manufacture Tislelizumab in China for...
12/29/2019
China Adopts New Law to Promote Basic Medical and Health Care
12/27/2019
Recent Executive Moves
12/27/2019
China Launches Mental Health Initiative for Students
12/27/2019
NMPA Initiates Drug Import & Export Permit Management System
12/27/2019
Janssen Secured Chinese Approval of Psoriasis Drug Tremfya (Gussetizum...
12/26/2019
Sanofi Files NDA for the World's Atopic Dermatitis Biologic Dupilumab ...
12/26/2019
China Lists Lemazolam for Regulation as Class 2 Psychotropic
12/25/2019
CDE Solicits Comments on Guidelines for Clinical Protocol of Biosimila...
12/23/2019
NMPA Issues the Technical Guidelines for Clinical Comparability Studie...
12/23/2019
BeiGene Announces Acceptance of a China sNDA for REVLIMID in Relapsed ...
Page:
128
/
360
Total number of articles:
10791
:
[First]
[<<]
[126]
[127]
[128]
[129]
[130]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit